Neurocognitive impairment in patients treated with protease inhibitor monotherapy or triple drug antiretroviral therapy.

by Ignacio Pérez-Valero, Alicia González-Baeza, Miriam Estébanez, María L Montes-Ramírez, Carmen Bayón, Federico Pulido, José I Bernardino, Francisco X Zamora, Susana Monge, Francisco Gaya, María Lagarde, Rafael Rubio, Asunción Hernando, Francisco Arnalich, José R Arribas
Published 2013-01-01